Switching to a Vaping Device: Evaluating Risk Reduction Among Quitline Treatment Failures

NCT03502200 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

350

Enrollment

OTHER

Sponsor class

Conditions

Smoking, Cigarette

Interventions

DEVICE: JUUL
OTHER: Treatment As Usual

Sponsor

Ohio State University Comprehensive Cancer Center

Collaborators

[object Object]